• Return to Headlines

Fibrogen Inc Down 18.4% Since SmarTrend Downtrend Call (FGEN)

By Shiri Gupta

SmarTrend identified a Downtrend for Fibrogen Inc (NASDAQ:FGEN) on August 6th, 2018 at $61.18. In approximately 2 months, Fibrogen Inc has returned 18.41% as of today's recent price of $49.91.

In the past 52 weeks, shares of Fibrogen Inc have traded between a low of $40.74 and a high of $68.55 and are now at $49.91, which is 23% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has declined 1.5%.

FibroGen, Inc. is a research-based pharmaceutical company focused on the discovery, development and commercialization of novel therapeutic agents to treat serious unmet medical needs. The Company has a global approach to the development and commercialization of its products.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Fibrogen Inc.

Log in and add Fibrogen Inc (FGEN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights fibrogen inc

Ticker(s): FGEN